This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Feb 7;115(2):156-8.

doi: 10.1016/j.ijcard.2006.05.003. Epub 2006 Jul 17.

Uric acid in CHF: marker or player in a metabolic disease?

Wolfram Doehner, Stephan von Haehling, Stefan D Anker

PMID: 16844250
DOI: 10.1016/j.ijcard.2006.05.003

Editorial

Uric acid in CHF: marker or player in a metabolic disease?

Wolfram Doehner et al. Int J Cardiol. 2007.

. 2007 Feb 7;115(2):156-8.

doi: 10.1016/j.ijcard.2006.05.003. Epub 2006 Jul 17.

Authors

Wolfram Doehner, Stephan von Haehling, Stefan D Anker

PMID: 16844250
DOI: 10.1016/j.ijcard.2006.05.003

No abstract available

PubMed Disclaimer

Comment on

Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
Jankowska EA, Ponikowska B, Majda J, Zymlinski R, Trzaska M, Reczuch K, Borodulin-Nadzieja L, Banasiak W, Ponikowski P. Jankowska EA, et al. Int J Cardiol. 2007 Feb 7;115(2):151-5. doi: 10.1016/j.ijcard.2005.10.033. Epub 2006 Jun 19. Int J Cardiol. 2007. PMID: 16782216

Similar articles

Uric acid, xanthine oxidase and heart failure: unresolved issues.
Verdejo H, Alcaino H, Greig D, Garcia L, Pizarro M, Chiong M, Castro P, Lavandero S. Verdejo H, et al. Eur J Heart Fail. 2008 Dec;10(12):1271-2. doi: 10.1016/j.ejheart.2008.10.006. Epub 2008 Nov 17. Eur J Heart Fail. 2008. PMID: 19010082 No abstract available.
[The role of uric acid in heart failure].
Alcaíno H, Greig D, Castro P, Verdejo H, Mellado R, García L, Díaz-Araya G, Quiroga C, Chiong M, Lavandero S. Alcaíno H, et al. Rev Med Chil. 2011 Apr;139(4):505-15. Epub 2011 Aug 25. Rev Med Chil. 2011. PMID: 21879191 Review. Spanish.
Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
Harzand A, Tamariz L, Hare JM. Harzand A, et al. Congest Heart Fail. 2012 May-Jun;18(3):179-82. doi: 10.1111/j.1751-7133.2011.00262.x. Epub 2011 Nov 9. Congest Heart Fail. 2012. PMID: 22587748 Review.
[Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
Calberg MJ, Kjøller E. Calberg MJ, et al. Ugeskr Laeger. 2005 Oct 3;167(40):3771-4. Ugeskr Laeger. 2005. PMID: 16221391 Review. Danish.
Hyperuricaemia and congestive heart failure: causation or association?
Gottlieb S. Gottlieb S. Eur Heart J. 1998 Dec;19(12):1746-7. Eur Heart J. 1998. PMID: 9886713 No abstract available.

See all similar articles

Cited by

Serelaxin in clinical development: past, present and future.
Unemori E. Unemori E. Br J Pharmacol. 2017 May;174(10):921-932. doi: 10.1111/bph.13695. Epub 2017 Jan 29. Br J Pharmacol. 2017. PMID: 28009437 Free PMC article. Review.
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.
Yen FS, Hsu CC, Li HL, Wei JC, Hwu CM. Yen FS, et al. PLoS One. 2020 Jun 23;15(6):e0234909. doi: 10.1371/journal.pone.0234909. eCollection 2020. PLoS One. 2020. PMID: 32574194 Free PMC article.
Prospective randomized comparison of effect on coronary endothelial and renal function between febuxostat and benzbromarone in hyperuricemic patients with coronary artery disease: EFEF study.
Nishino M, Egami Y, Nakamura H, Ukita K, Kawamura A, Matsuhiro Y, Yasumoto K, Tsuda M, Tanaka A, Okamoto N, Matsunaga-Lee Y, Yano M, Shutta R, Tanouchi J. Nishino M, et al. Health Sci Rep. 2022 Mar 22;5(2):e563. doi: 10.1002/hsr2.563. eCollection 2022 Mar. Health Sci Rep. 2022. PMID: 35356803 Free PMC article.
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout.
Yen FS, Hsu CC, Li HL, Wei JC, Hwu CM. Yen FS, et al. Front Med (Lausanne). 2020 Feb 27;7:63. doi: 10.3389/fmed.2020.00063. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32175324 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information